• 08/07/2025, Sophia Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of July 31, 2025

    Disclosure of total number of voting rights and number of shares in the capital as of July 31, 2025, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20250807_PR_shares_votingrights_July2025.pdf
  • 08/01/2025,

    Closing of a capital increase

    Our press release here Not to be published, distributed or disseminated, directly or indirectly, in the United States of America, Australia, Canada, South Africa and Japan
    Read more
  • 07/21/2025, Sophia Antipolis, France

    Median Technologies launches a capital increase

    Press Release – July 21, 2025 – 6:15 pm CEST More information here 
    Read more
  • 07/11/2025, Sophia Antipolis, France

    Median Technologies signs financial agreement for up to €37.5 million new financing facility with the European Investment Bank (EIB)

    Median Technologies announced today that the Company signed a financial agreement with the European Investment Bank (EIB) for a new financing facility of up to €37.5 million, on July 11, 2025.
    Read more Download 20250711_PR_EIBFinancing_EN_final.pdf
  • 07/09/2025, Sophia Antipolis

    Half year liquidity contract statement

    Under the liquidity contract entrusted by Median Technologies to TP ICAP (Europe), the following resources were listed in the liquidity account as of June 30, 2025.
    Read more Download 20250709_PR_liquiditycont_HY12025_EN.pdf
  • 07/07/2025, Sophia Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of June 30, 2025

    Disclosure of total number of voting rights and number of shares in the capital as of June 30, 2025, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20250707_PR_shares_votingrights_June2025.pdf
  • 07/01/2025, Sophia Antipolis, France

    Median Technologies files European application for Class IIb CE marking of its AI-based Software as a Medical Device for Lung Cancer Screening, eyonis® LCS

    Median Technologies files European application for Class IIb CE marking of eyonis® LCS. Concurrently to CE marking, Median has also applied for ISO 13485 certification for the Quality Management System supporting the manufacturing of eyonis ® LCS.
    Read more Download 20250701_PR_CEMark_EN_final.pdf
  • 06/10/2025, Sophia Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of May 31, 2025

    Disclosure of total number of voting rights and number of shares in the capital as of May 31, 2025, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20250610_PR_shares_votingrights_May2025.pdf
  • 05/28/2025, Sophia Antipolis, France

    Median Technologies announces the availability of the preparatory documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 17, 2025

    Press release – For immediate release – 5:45 pm CEST Median Technologies announces the availability of the preparatory documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 17, 2025 The shareholders of Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”) are invited to participate in the Shareholders’ Ordinary and Extraordinary General […]
    Read more Download 20250528_PR_OEGM_17June2025_EN.pdf
  • 05/27/2025, Sophia Antipolis, France

    Median Technologies to showcase iCRO’s central and AI-powered imaging services for oncology clinical trials at ASCO 2025

    Median Technologies announced today that the Company will be participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place from May 30 to June 2, McCormick Place, Chicago, IL, USA. Median’s team will be hosting interested parties at booth #11046, South Building, Hall A, from May 31 to June 2 (exhibit dates), 9:00 am – 5:00 pm CT, where it will share the most recent advances for its central and AI-powered imaging services for oncology clinical trials.
    Read more Download 20250527_PR_ASCO2025_EN_final.pdf
    • 1 … 42